热门资讯> 正文

Fulfillet Therapeutics GAAP每股收益-0.25美元击败0.05美元

2026-04-27 19:05

Fulcrum Therapeutics(FULC) 0

Fulcrum Therapeutics press release (FULC): Q1 GAAP EPS of -$0.25 beats by $0.05.
Ended the first quarter of 2026 with $333.3 million in cash, cash equivalents, and marketable securities; cash runway into 2029

More on Fulcrum Therapeutics

Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion
Fulcrum Therapeutics, Inc. (FULC) Q4 2025 Earnings Call Transcript
Fulcrum Therapeutics GAAP EPS of -$0.31 in-line
Seeking Alpha’s Quant Rating on Fulcrum Therapeutics
Historical earnings data for Fulcrum Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。